Milestone Pharmaceuticals Correlations

MIST Stock

USD 1.98 0.03 1.54%

The current 90-days correlation between Milestone Pharmaceuticals and DiaMedica Therapeutics is 0.05 (i.e., Significant diversification). The correlation of Milestone Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Milestone Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Milestone Pharmaceuticals and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Moving together with Milestone Stock

0.63	DNLI	Denali Therapeutics	Pair Corr
0.65	VERA	Vera Therapeutics	Pair Corr

Moving against Milestone Stock

0.51	VALN	Valneva SE ADR	Pair Corr
0.33	DRMA	Dermata Therapeutics	Pair Corr
0.32	ME	23Andme Holding	Pair Corr
0.5	VRCA	Verrica Pharmaceuticals	Pair Corr
0.44	VIRX	Viracta Therapeutics	Pair Corr
0.35	DYAI	Dyadic International	Pair Corr
0.33	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.31	VTGN	VistaGen Therapeutics	Pair Corr

Related Correlations Analysis

	DMAC	MCRB	IKT	ONCY	SCPH	LIFE	XFOR	GRTX	TERN	DAWN
DMAC		-0.19	0.35	0.5	-0.43	-0.1	-0.51	0.1	0.22	0.39	DMAC
MCRB	-0.19		-0.61	-0.61	0.59	0.06	0.62	0.33	0.79	-0.26	MCRB
IKT	0.35	-0.61		0.6	-0.52	-0.19	-0.66	-0.44	-0.53	0.73	IKT
ONCY	0.5	-0.61	0.6		-0.64	0.11	-0.85	-0.4	-0.44	0.37	ONCY
SCPH	-0.43	0.59	-0.52	-0.64		0.2	0.81	0.33	0.5	-0.3	SCPH
LIFE	-0.1	0.06	-0.19	0.11	0.2		-0.01	0.22	-0.04	-0.35	LIFE
XFOR	-0.51	0.62	-0.66	-0.85	0.81	-0.01		0.43	0.54	-0.31	XFOR
GRTX	0.1	0.33	-0.44	-0.4	0.33	0.22	0.43		0.43	-0.25	GRTX
TERN	0.22	0.79	-0.53	-0.44	0.5	-0.04	0.54	0.43		-0.1	TERN
DAWN	0.39	-0.26	0.73	0.37	-0.3	-0.35	-0.31	-0.25	-0.1		DAWN
	DMAC	MCRB	IKT	ONCY	SCPH	LIFE	XFOR	GRTX	TERN	DAWN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XFOR	+ 0.81	SCPH
TERN	+ 0.79	MCRB
DAWN	+ 0.73	IKT
XFOR	+ 0.62	MCRB
ONCY	+ 0.6	IKT
SCPH	+ 0.59	MCRB

High negative correlations

XFOR	- 0.85	ONCY
XFOR	- 0.66	IKT
SCPH	- 0.64	ONCY
ONCY	- 0.61	MCRB
IKT	- 0.61	MCRB
TERN	- 0.53	IKT

Risk-Adjusted Indicators

There is a big difference between Milestone Stock performing well and Milestone Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Milestone Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DMAC	2.19	0.48	0.11	(0.82)	2.00	(2.52)	5.20	(3.23)	12.63
MCRB	4.04	(0.26)	0.00	(0.83)	0.00	0.00	8.43	(8.57)	26.87
IKT	4.36	1.22	0.28	1.35	3.71	(5.28)	13.22	(6.15)	30.50
ONCY	3.31	0.29	0.02	(0.71)	3.10	(5.22)	7.83	(5.34)	36.56
SCPH	2.69	(0.38)	0.00	(0.03)	0.00	0.00	5.64	(4.91)	18.96
LIFE	2.57	0.23	0.08	0.37	2.62	(3.23)	6.45	(5.29)	28.98
XFOR	3.15	(0.27)	(0.03)	0.01	4.21	(3.74)	6.06	(5.71)	25.63
GRTX	2.93	(0.04)	0.00	(0.27)	0.00	0.00	7.31	(5.84)	18.16
TERN	3.47	0.03	0.02	0.19	3.62	(4.31)	7.89	(5.96)	34.09
DAWN	1.87	0.20	0.08	0.37	2.06	(2.03)	3.84	(3.54)	9.82

Milestone Pharmaceuticals Corporate Management

Anita Holz	VP Affairs	Profile
Guy Rousseau	SVP Management	Profile
FACC FAHA	Chief Board	Profile
Jeffrey Nelson	Chief Officer	Profile
Roshan Girglani	Vice Marketing	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC